Not classified as an open-market trade.
Traded Mar 30, 2026 · Filed Apr 1, 2026
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$840,169
Shares × reported transaction price
61 days after results of Jan 28, 2026, 3 days before results of Apr 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $355.28 on Mar 30, 2026, 60% above its 52-week low and 27% below its high, after a 15% drop over the previous 30 trading days
52-week range $221.86 (Apr 8, 2025) to $489.88 (Dec 16, 2025), 50% of the way up, from 251 adjusted closes. 30 trading days earlier: $417.44 on Feb 13, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -4.2% | +3.7% | -7.8% |
| 30 days | +8.8% | +9.5% | -0.6% |
| 90 days | +17.9% | +13.7% | +4.2% |
| 180 days | -2.1% | +16.5% | -18.7% |
Past results only. Not a forecast.
Not classified as an open-market trade.
2 different filers disclosed TSLA within 90 days. Disclosed 25 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.